HJ Burstein
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
-
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 18
- Cancer Treatment and Pharmacology 15
- HER2/EGFR in Cancer Research 9
- Lung Cancer Research Studies 1
-
- Advanced Breast Cancer Therapies 11
- Co-authors
- Hope S. Rugo (1 shared paper)Eric P. Winer (7 shared papers)Mary Collier (1 shared paper)Charles M. Baum (1 shared paper)Melody Cobleigh (1 shared paper)Anthony Elias (1 shared paper)Peter D. Eisenberg (1 shared paper)M. Pegram (1 shared paper)
- Journals
- Cancer Research (14 papers)Journal of Clinical Oncology (7 papers)European Journal of Cancer (1 paper)Clinical Chemistry (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesBelgiumSwitzerland
In The Last Decade
HJ Burstein
25 papers receiving 218 citations
Peers
Comparison fields: 5 of 30
- Oncology 168
- Cancer Research 74
- Radiology, Nuclear Medicine and Imaging 41
- Pulmonary and Respiratory Medicine 50
- Genetics 7
Countries citing papers authored by HJ Burstein
This map shows the geographic impact of HJ Burstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HJ Burstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HJ Burstein more than expected).
Fields of papers citing papers by HJ Burstein
This network shows the impact of papers produced by HJ Burstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HJ Burstein. The network helps show where HJ Burstein may publish in the future.
Co-authors
The 25 scholars most cited alongside HJ Burstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 57 | |
| 2 | 2009 | 37 | |
| 3 | 2013 | 22 | |
| 4 | 2011 | 22 | |
| 5 | 2002 | 11 | |
| 6 | 2006 | 9 | |
| 7 | 2018 | 8 | |
| 8 | 2009 | 7 | |
| 9 | 2010 | 6 | |
| 10 | 2007 | 5 | |
| 11 | 2001 | 5 | |
| 12 | 2010 | 5 | |
| 13 | 2008 | 5 | |
| 14 | 1986 | 4 | |
| 15 | 2010 | 4 | |
| 16 | 2018 | 3 | |
| 17 | 2011 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2011 | 2 | |
| 20 | 2018 | 1 |
About HJ Burstein
HJ Burstein is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Surgery, having authored 25 papers that have together received 223 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (13 papers), Advanced Breast Cancer Therapies (11 papers), HER2/EGFR in Cancer Research (9 papers), Estrogen and related hormone effects (2 papers), Lung Cancer Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper) and Angiogenesis and VEGF in Cancer (1 paper). The work is most often cited by research in Oncology (168 citations), Cancer Research (74 citations), Radiology, Nuclear Medicine and Imaging (41 citations), Pulmonary and Respiratory Medicine (50 citations) and Genetics (7 citations). HJ Burstein has collaborated with scholars based in United States, Belgium and Switzerland. Frequent co-authors include Hope S. Rugo, Eric P. Winer, Mary Collier, Charles M. Baum, Melody Cobleigh, Anthony Elias, Peter D. Eisenberg, M. Pegram, Kathy D. Miller and L. Dirix. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, European Journal of Cancer, Clinical Chemistry and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.